A diet-induced mouse model for glutaric aciduria type I.
暂无分享,去创建一个
J. Connor | E. Wolpert | D. Antonetti | K. Cheng | S. Goodman | M. Woontner | J. Lazovic | W. J. Zinnanti | Michael B. Smith
[1] S. Kölker,et al. Bioenergetics in Glutaryl-Coenzyme A Dehydrogenase Deficiency , 2005, Journal of Biological Chemistry.
[2] C. Bührer,et al. Glutaric Acid and Its Metabolites Cause Apoptosis in Immature Oligodendrocytes: A Novel Mechanism of White Matter Degeneration in Glutaryl-CoA Dehydrogenase Deficiency , 2005, Pediatric Research.
[3] M. D. Del Bigio,et al. Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. , 2005, Brain : a journal of neurology.
[4] K. Strauss. Glutaric aciduria type 1: a clinician's view of progress. , 2005, Brain : a journal of neurology.
[5] K. Strauss,et al. Vascular dysfunction as an additional pathomechanism in glutaric aciduria type I , 2004, Journal of Inherited Metabolic Disease.
[6] M. R. Bigio,et al. Preliminary attempts to establish a rat model of striatal injury in glutaric acidaemia type I , 2004, Journal of Inherited Metabolic Disease.
[7] K. Strauss,et al. Challenges for basic research in glutaryl-CoA dehydrogenase deficiency , 2004, Journal of Inherited Metabolic Disease.
[8] R. Ramsay,et al. Carnitine acyltransferases and their influence on CoA pools in health and disease. , 2004, Molecular aspects of medicine.
[9] Takeshi Kimura,et al. Thirteen-Week Oral Toxicity Study of L-Lysine Hydrochloride in Rats , 2004, International journal of toxicology.
[10] J. Walecki,et al. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy. , 2003, Hepato-gastroenterology.
[11] K. Strauss,et al. Type I glutaric aciduria, part 2: A model of acute striatal necrosis , 2003, American journal of medical genetics. Part C, Seminars in medical genetics.
[12] E. Puffenberger,et al. Type I glutaric aciduria, part 1: Natural history of 77 patients , 2003, American journal of medical genetics. Part C, Seminars in medical genetics.
[13] G. Hoffmann,et al. Adult onset glutaric aciduria type I presenting with a leukoencephalopathy , 2003, Neurology.
[14] J. Dichgans,et al. Adult onset glutaric aciduria type I presenting with a leukoencephalopathy , 2002, Neurology.
[15] E. Puffenberger,et al. Diagnosis and treatment of maple syrup disease: a study of 36 patients. , 2002, Pediatrics.
[16] J. Hoeijmakers,et al. Premature Aging in Mice Deficient in DNA Repair and Transcription , 2002, Science.
[17] B. Kleinschmidt-DeMasters,et al. Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I. , 2002, Human molecular genetics.
[18] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[19] Vincent Schmithorst,et al. Simultaneous correction of ghost and geometric distortion artifacts in EPI using a multiecho reference scan , 2001, IEEE Transactions on Medical Imaging.
[20] C. Scriver,et al. The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.
[21] C. Palmeira,et al. Induction of the mitochondrial permeability transition in vitro by short-chain carboxylic acids. , 2000, Biochemical and Biophysical Research Communications - BBRC.
[22] F. Condé,et al. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies , 2000, Neuroscience.
[23] B. Ahlemeyer,et al. Maturation-Dependent Neurotoxicity of 3-Hydroxyglutaric and Glutaric Acids In Vitro : A New Pathophysiologic Approach to Glutaryl-CoA Dehydrogenase Deficiency , 2000, Pediatric Research.
[24] Q. Smith. Transport of glutamate and other amino acids at the blood-brain barrier. , 2000, The Journal of nutrition.
[25] T W Gardner,et al. Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties. , 2000, Microvascular research.
[26] G. Sutherland,et al. Serial magnetic resonance imaging of rat brain after induction of renal hypertension. , 1999, Stroke.
[27] J. Marrero,et al. Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice: characterization of a new animal model. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[28] E. Christensen,et al. Glutaric aciduria type I: Pathomechanisms of neurodegeneration , 1999, Journal of Inherited Metabolic Disease.
[29] T. Crenshaw,et al. Mitochondrial lysine uptake limits hepatic lysine oxidation in rats fed diets containing 5, 20 or 60% casein. , 1998, The Journal of nutrition.
[30] M. Wajner,et al. Pharmacological evidence for GABAergic and glutamatergic involvement in the convulsant and behavioral effects of glutaric acid , 1998, Brain Research.
[31] D. Morton,et al. Diagnosis and management of glutaric aciduria type I , 1998, Journal of Inherited Metabolic Disease.
[32] A. Morton,et al. Changes in blood–brain barrier permeability following neurotoxic lesions of rat brain can be visualised with trypan blue , 1998, Journal of Neuroscience Methods.
[33] F. Podo,et al. Transient global brain ischemia in the rat: spatial distribution, extension, and evolution of lesions evaluated by magnetic resonance imaging , 1997, Magnetic Resonance Materials in Physics, Biology and Medicine.
[34] B. Kreft,et al. Subdural hemorrhage as an initial sign of glutaric aciduria type 1: A diagnostic pitfall , 1996, Pediatric Radiology.
[35] H. Osaka,et al. Two cases of glutaric aciduria type 1: Clinical and neuropathological findings , 1994, Journal of the Neurological Sciences.
[36] H. Osaka,et al. Chronic subdural hematoma, as an initial manifestation of glutaric aciduria type-1 , 1993, Brain and Development.
[37] J. Gomori,et al. Striatal degeneration and spongy myelinopathy in glutaric acidemia , 1992, Journal of the Neurological Sciences.
[38] C. Stanley,et al. Acute profound dystonia in infants with glutaric acidemia. , 1989, Pediatrics.
[39] R K Craig,et al. Methods in molecular medicine. , 1987, British medical journal.
[40] M. Norenberg,et al. Glutaric aciduria: biochemical and morphologic considerations. , 1977, The Journal of pediatrics.
[41] S. Goodman,et al. Inhibition of brain glutamate decarboxylase by glutarate, glutaconate, and beta-hydroxyglutarate: explanation of the symptoms in glutaric aciduria? , 1976, Clinica chimica acta; international journal of clinical chemistry.
[42] Saul G. Cohen,et al. Requirements for Stereospecificity in Hydrolysis by Chymotrypsin: Diethyl β-Acetamidoglutarate , 1960, Nature.
[43] J. Winn,et al. Brain , 1878, The Lancet.
[44] D. Danks,et al. Neuropathology in glutaric acidaemia type 1 , 2004, Acta Neuropathologica.
[45] E. Wolpert,et al. Isolation and characterization of retinal endothelial cells. , 2003, Methods in molecular medicine.
[46] M. Pourfarzam,et al. Glutaryl-CoA dehydrogenase deficiency: region-specific analysis of organic acids and acylcarnitines in post mortem brain predicts vulnerability of the putamen. , 2003, Neuropediatrics.
[47] L. Hartley,et al. Glutaric aciduria type 1 and nonaccidental head injury. , 2001, Pediatrics.
[48] H. Taegtmeyer,et al. Propionyl-L-carnitine-mediated improvement in contractile function of rat hearts oxidizing acetoacetate. , 1995, The American journal of physiology.
[49] C. Greenberg,et al. Phenotypic variability in glutaric aciduria type I: Report of fourteen cases in five Canadian Indian kindreds. , 1991, The Journal of pediatrics.
[50] N. Benevenga,et al. Adverse effects of excessive consumption of amino acids. , 1984, Annual review of nutrition.